21 related articles for article (PubMed ID: 2498278)
1. Murepavadin promotes the killing efficacies of aminoglycoside antibiotics against
Wei X; Gao J; Zhou D; Xu C; Chen P; Chen S; Zhang Y; Liu X; Li G; Zhu G; Liu H; Li J; Geng B; Gao L; Cheng Z; Lamont IL; Pletzer D; Jin Y; Jin S; Wu W
Antimicrob Agents Chemother; 2024 Apr; 68(4):e0153923. PubMed ID: 38470195
[TBL] [Abstract][Full Text] [Related]
2. Effect of malate on the activity of ciprofloxacin against
Bao X; Goeteyn E; Crabbé A; Coenye T
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0068223. PubMed ID: 37819115
[TBL] [Abstract][Full Text] [Related]
3. Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
Skorup P; Maudsdotter L; Lipcsey M; Castegren M; Larsson A; Jonsson AB; Sjölin J
PLoS One; 2014; 9(2):e90441. PubMed ID: 24587365
[TBL] [Abstract][Full Text] [Related]
4. [In vitro combination effects of doripenem with aminoglycoside or ciprofloxacin against Pseudomonas aeruginosa].
Anan N; Toba S; Ito A; Nakamura R; Tsuji M
Jpn J Antibiot; 2011 Aug; 64(4):203-16. PubMed ID: 22066345
[TBL] [Abstract][Full Text] [Related]
5. Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Murray PR
Antimicrob Agents Chemother; 1980 Mar; 17(3):474-6. PubMed ID: 6252830
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Pfaller M; Bale M; Preston T; Howard W; Koontz F
Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo synergy between ceftriaxone and aminoglycosides against Pseudomonas aeruginosa.
Angehrn P
Eur J Clin Microbiol; 1983 Oct; 2(5):489-95. PubMed ID: 6315424
[TBL] [Abstract][Full Text] [Related]
8. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
9. Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
Willcox MD
Clin Exp Optom; 2011 Mar; 94(2):161-8. PubMed ID: 21083760
[TBL] [Abstract][Full Text] [Related]
10. L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Valiant ME; Gilfillan EC; Gadebusch HH; Pelak BA
J Antibiot (Tokyo); 1989 May; 42(5):807-14. PubMed ID: 2498278
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
